Retinal thickness as a biomarker of cognitive impairment in manifest Huntington's disease.

Ane Murueta-GoyenaRocío Del PinoMarian AceraSara Teijeira-PortasDavid RomeroUnai AyalaTamara Fernández-ValleBeatriz TijeroIñigo GabilondoJuan Carlos Gómez Esteban

Published in: Journal of neurology (2023)

In line with other neurodegenerative diseases, OCT is a potential biomarker of cognitive status in manifest HD. Future prospective studies are needed to evaluate OCT as a potential surrogate marker of cognitive decline in HD.

Keyphrases

optical coherence tomography
cognitive decline
cognitive impairment
diabetic retinopathy
mild cognitive impairment
optic nerve
current status
case control
human health
climate change